Queen Mary University of London leads £1.7 million project to revolutionise drug discovery with next-generation organ-chip technology

Faculty of Science and Engineering
Centre for Bioengineering

16 May 2024

Queen Mary University of London in collaboration with a consortium of leading pharmaceutical companies, organ-chip technology providers, and regulatory bodies, has secured a £1.7 million research grant from the Engineering and Physical Sciences Research Council (EPSRC) to develop a groundbreaking approach to drug discovery.

Read more


Updated by: Ilyana Zolotareva